Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Recall Image cb1November 27 2017

A Class 2 drugs recall for batches of Lipitor 80mg and of generic atorvastatin 80mg under the Almus livery has been issued.

The MHRA’s alert says: “Pfizer is recalling the above batches as a precaution due to an out of specification result for microbiological testing during routine stability studies on a batch of the product which was not released to the market.”

The batches in the recall “were identified as being potentially affected by the same issue during the root cause investigation, although no out of specification microbiological results have been reported for these batches.”

The three batches involved – T43166 and T43170 (Lipitor) and T43157 (Almus) – with pack sizes each of 28 film-coated tablets, have been distributed from August 30 onwards, and all have expiry date of January 31 2020.

Medical information enquiries should be directed to Pfizer Medical Information on 01304 616161. Stock enquires should be directed to the local branch of Alliance Healthcare.

Link:
MHRA Class 2 medicines recall    

June 22 2018 A review into the scheduling of cannabis for medicinal purposes will look for “significant medical and therapeutic benefits” before a decision is made.
June 19 2018 A practice-based audit will seek to explore community pharmacy’s contribution in supporting girls and women of childbearing potential who need to take valproate medicines. Launched by...